Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients.
about
Utility of patient-derived lymphoblastoid cell lines as an ex vivo capecitabine sensitivity prediction model for breast cancer patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Utility of patient-derived lym ...... el for breast cancer patients.
@en
Utility of patient-derived lym ...... el for breast cancer patients.
@nl
type
label
Utility of patient-derived lym ...... el for breast cancer patients.
@en
Utility of patient-derived lym ...... el for breast cancer patients.
@nl
prefLabel
Utility of patient-derived lym ...... el for breast cancer patients.
@en
Utility of patient-derived lym ...... el for breast cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Utility of patient-derived lym ...... del for breast cancer patients
@en
P2093
Andres Forero
Bonnie LaCroix
Catherine Van Poznak
Dana Ziliak
Divya Lenkala
Gladys Morrison
Hope S Rugo
Peter H O'Donnell
Phuong Khanh Morrow
Rita Nanda
P2860
P304
38359-38366
P356
10.18632/ONCOTARGET.9521
P407
P577
2016-06-01T00:00:00Z